Enterprise Solutions Webinars
-
CDMO + Emerging Bio Partnership With Forge's John Maslowski And Ray's Jenny Holt
10/29/2023
What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its CDMO? Jenny Holt, Chief Development Officer at the biopharma company Ray Therapeutics has some opinions. So does John Maslowski, Chief Commercial Officer at the CDMO Forge Biologics. Think they align?
-
mRNA Supply Chain And Critical Component Risks
10/16/2023
What challenges do you consider the most formidable in your own mRNA therapeutic development environments?
-
LNP Stability In mRNA Therapeutics
10/16/2023
Learn more about LNP complexity, fragility, and other lipid nanoparticle considerations in this segment from the Bioprocess Online Live digital event Risk Reduction In mRNA Therapeutic Development.
-
The Future Of Cell Therapy Development And Delivery
10/6/2023
Experts discuss the latest strategies for navigating the complexities of cell therapy development and identify clinical development best practices for a successful execution.
-
The Importance Of Fostering Strategic Partnerships
10/6/2023
Addressing obstacles through a patient-focused approach and leveraging a strategic relationship is necessary to find the solutions that are needed to propel cell therapies toward approval.
-
The Technology Debate: Single-Use vs. Stainless Steel
10/4/2023
In this discussion you will explore the multi-point case for adopting single-use technologies throughout the workflow via an economic, operational, and environmental sustainability lens.
-
Commercial Readiness with Orca Bio's Dan Kirby
9/14/2023
Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is to play in drug sales and marketing.
-
An Advanced Single-Use Solution for Downstream Bioprocessing
9/5/2023
A single-use chromatography system is offering an innovative solution tailored to meet the needs of evolving downstream purification bioprocesses.
-
Building LEO Pharma's U.S. Presence with Brian Hilberdink
8/23/2023
In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped veteran biopharma leader Brian Hilberdink to lead its U.S. operations.
-
Managing Momentum With Rezolute Bio's Nevan Charles Elam, JD
8/16/2023
Since we last spoke in the Spring of 2021, Nevan Charles Elam, JD has managed to advance both of small-but-mighty Rezolute Bio's candidates onto the next phases of their journey. This year, on the back of a $130 million investment, Rezolute Bio is prepping its RZ358 candidate, a monoclonal antibody for congenital hyperinsulinism, for a pivotal phase 3 trial. On this week's episode of the Business of Biotech, we're settling in for an interrogation of Elam on the management principles of maintaining multi-candidate clinical momentum among highly disparate candidates and raising big dollars as a small biotech.